Please login to the form below

Not currently logged in
Email:
Password:

health technology assessments

This page shows the latest health technology assessments news and features for those working in and with pharma, biotech and healthcare.

Promoting off-label use: where to draw the line?

Promoting off-label use: where to draw the line?

public health risk, compassionate use for groups of patients or for individual patients on a named basis. ... The approach put forward by the report undermines both the EU regulatory system for approving medicines and the national pricing and

Latest news

More from news
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • Managed Access Programmes: a powerful source of real-world insight Managed Access Programmes: a powerful source of real-world insight

    Real-world evidence can be collected retrospectively or prospectively. The former involves interrogating databases containing patient data collected by health insurances, hospitals and national health services. ... 6. We have received reports of data

  • Managed Access Programmes: a powerful source of real-world insight Managed Access Programmes: a powerful source of real-world insight

    Real-world evidence can be collected retrospectively or prospectively. The former involves interrogating databases containing patient data collected by health insurances, hospitals and national health services. ... 6. We have received reports of data

  • Getting below the surface: regional and local market access Getting below the surface: regional and local market access

    of the different health technology assessments (HTAs) and pricing and reimbursement processes. ... These are then further divided into almost 140 local health authorities and over 800 hospitals.

  • Taking a strategic approach Taking a strategic approach

    Titeux appreciates that, as a company, there is a possibility for collaboration on Relative Efficacy Assessments, but less so for full health technology appraisals. ... And he acknowledges that a new European process risks creating an additional,

  • Novo Nordisk’s Klaus Henning Jensen on trends in medical affairs Novo Nordisk’s Klaus Henning Jensen on trends in medical affairs

    It goes without saying that health technology assessments have been on the rise for a long time,” explains Novo Nordisk's head of clinical, medical and regulatory for the UK &Ireland ... of health technology assessment bodies like NICE, whose

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Can rare diseases be a viable option for the pharma industry?

    In an environment where a successful Health Technology Assessment (HTA), showing substantial benefit over the current standard of care, will become a requirement for any new drug approval post 2014, orphan ... Department of Health &Human Services, Office

  • Briggids Limited

    Briggids Limited. Briggids is a dynamic, global organisation with extensive experience in systematic reviews, health technology assessments, therapeutic value propositions/market access, landscape mapping and medical communications.

  • Market access

    International health economics agency specialising in systematic review, modeling, HTA and market access. ... Briggids is a dynamic, global organisation with extensive experience in systematic reviews, health technology assessments, therapeutic value

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics